Lung function response to 12-week treatment with combined inhalation of long-acting β2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease

Lung

Volumn 186, Issue 6, 2008, Pages 381-386

  Kim, Woo Jin ^a   Oh, Yeon Mok ^b   Sung, Joohon ^c   Kim, Tae Hyung ^d   Huh, Jin Won ^e   Jung, Hoon ^e   Lee, Ji Hyun ^f   Kim, Eun Kyung ^f   Lee, Jin Hwa ^g   Lee, Sang Min ^h   Lee, Sangyeub ⁱ   Lim, Seong Yong ^j   Shin, Tae Rim ^k   Yoon, Ho Il ^l   Kwon, Sung Youn ^l   Lee, Sang Do ^b  

^a Kangwon National University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

^d Hanyang University Guri Hospital   (South Korea)

^e Inje University   (South Korea)

^f CHA University   (South Korea)

^g Mokdong Hospital   (South Korea)

^h Seoul National University Hospital   (South Korea)

ⁱ Korea University College of Medicine   (South Korea)

^j Sungkyunkwan University School of Medicine   (South Korea)

^k Hallym University College of Medicine   (South Korea)

^l Seoul National University Bundang Hospital   (South Korea)

more..

Author keywords

agonist; COPD; Polymorphism

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE PROPIONATE; GENOMIC DNA; GLUCOCORTICOID; GLYCINE; LONG ACTING DRUG; SALBUTAMOL; SALMETEROL;

ADRB2 GENE; ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CODON; COMPUTER ASSISTED TOMOGRAPHY; DNA POLYMORPHISM; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC VARIABILITY; GENOTYPE; HUMAN; INHALER; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPIROMETRY; TREATMENT DURATION; TREATMENT RESPONSE; URINALYSIS;

ADMINISTRATION, INHALATION; AGED; ALBUTEROL; ANALYSIS OF VARIANCE; ANDROSTADIENES; BRONCHODILATOR AGENTS; COHORT STUDIES; FEMALE; GENOTYPE; GLUCOCORTICOIDS; HUMANS; KOREA; LUNG; MALE; MIDDLE AGED; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, ADRENERGIC, BETA-2; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 55949113807     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-008-9103-9     Document Type: Article

References (28)

1. 2-adrenergic receptor and asthma Am J Respir Crit Care Med 156 S156 S162
2. JJ Lima DB Thomason MHN Mohamed LV Eberle TH Self JA Johnson 1999 Impact of genetic polymorphisms of the β2-adrenergic receptor on albuterol bronchodilator pharmacodynamics Clin Pharmacol Ther 65 519 525
3. 2-adrenoceptor and response to albuterol in children with or without a history of wheezing J Clin Invest 100 3184 3188
4. 2-adrenoceptor gene Clin Exp Allergy 35 1162 1167
5. 2-adrenergic receptor on the response to regular use of albuterol in asthma Am J Respir Crit Care Med 162 75 80
6. E Israel VM Chinchilli JG Ford HA Boushey R Cherniack TJ Craig A Deykin JK Fagan JV Fahy J Fish M Kraft SJ Kunselman SC Lazarus RF Lemanske Jr SB Liggett RJ Martin N Mitra SP Peters E Silverman CA Sorkness SJ Szefler ME Wechsler ST Weiss JM Drazen National Heart, Lung, Blood Institute's Asthma Clinical Research Network 2004 Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomized, placebo-controlled cross-over trial Lancet 364 1505 1512
7. 2-agonist therapy in asthma Eur Respir J 11 589 593
8. 2-adrenergic receptor polymorphisms and response to salmeterol Am J Respir Crit Care Med 173 519 526
9. 2- adrenergic receptor genotype in subjects with persistent asthma J Allergy Clin Immunol 118 809 816
10. J Vestbo R Pauwelst JA Anderson P Jones P Calverley 2005 Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease Thorax 60 301 304
11. M Cazzola R Dahl 2004 Inhaled combination therapy with long-acting β2-agonists and corticosteroids in stable COPD Chest 126 220 237
12. PM Calverley JA Anderson B Celli GT Ferguson C Jenkins PW Jones JC Yates J; TORCH Vestbo investigators 2007 Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 775 789
13. American Thoracic Society 1995 Standardization of spirometry, 1994 update Am J Respir Crit Care Med 152 1107 1136
14. SL Zeger KY Liang PS Albert 1988 Models for longitudinal data: a generalized estimating equation approach Biometrics 44 1049 1060
15. DJ Schaid CM Rowland DE Tines RM Jacobson GA Poland 2002 Score tests for association between traits and haplotypes when linkage phase is ambiguous Am J Hum Genet 70 425 434
16. 2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD Chest 132 1485 1492
17. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties Biochemistry 33 9414 9419
18. SA Green J Turki P Bejarano IP Hall SB Leggett 1995 Influence of β2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle Am J Respir Cell Mol Biol 13 25 33
19. 2-adrenoreceptor on desensitization in human lung mast cells Pharmacogenetics 10 153 162
20. 2-adrenergic receptor on agonist-mediated vascular desensitization N Engl J Med 345 1030 1035
21. 2-adrenergic receptor genotype on airway function during exercise in healthy adults Chest 129 762 770
22. DD Sin SF Man 2006 Corticosteroids and adrenoceptor agonists: The compliments for combination therapy in chronic airway diseases Eur J Pharmacol 533 28 35
23. C Fenton GM Keating 2004 Inhaled salmeterol/fluticasone propionate. A review of its use in chronic obstructive pulmonary disease Drugs 64 1975 1996
24. 2- agonist therapy: a pharmcogenetic analysis of two randomized studies Lancet 370 2118 2125
25. S Choudhry N Ung PC Avila E Ziv S Nazario J Casal A Torres JD Gorman K Salari JR Rodriguez-Santana M Toscano JS Sylvia M Alioto RA Castro M Salazar I Gomez JK Fagan J Salas S Clark C Lilly H Matallana M Selman R Chapela D Sheppard ST Weiss JG Ford HA Boushey JM Drazen W Rodriguez-Cintron EK Silverman EG Burchard 2005 Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma Am J Respir Crit Care Med 171 563 570
26. 2-adrenoceptor gene in Japanese asthmatic and non-asthmatic subjects Allergol Int 55 191 198
27. GA Hawkins K Tantisira DA Meyers EJ Ampleford WC Moore B Klanderman SB Liggett SP Peters ST Weiss ER Bleecker 2006 Sequence, haplotype, and association analysis of ADRβ2 in a multiethnic asthma case-control study Am J Respir Crit Care Med 174 1101 1109
28. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness Proc Natl Acad Sci USA 97 10483 10488